222
Views
16
CrossRef citations to date
0
Altmetric
Original

Predictors of Benzodiazepine Discontinuation in Subjects Manifesting Complicated Dependence

, , &
Pages 499-510 | Published online: 03 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tauheed Zaman, Tessa L. Rife, Steven L. Batki & David L. Pennington. (2018) An electronic intervention to improve safety for pain patients co-prescribed chronic opioids and benzodiazepines. Substance Abuse 39:4, pages 441-448.
Read now

Articles from other publishers (15)

Matthew Tennant, Chris Frampton, Roger Mulder & Ben Beaglehole. (2023) Polypharmacy in the treatment of people diagnosed with borderline personality disorder: repeated cross-sectional study using New Zealand's national databases. BJPsych Open 9:6.
Crossref
Amber N. Edinoff, Catherine A. Nix, Janice Hollier, Caroline E. Sagrera, Blake M. Delacroix, Tunde Abubakar, Elyse M. Cornett, Adam M. Kaye & Alan D. Kaye. (2021) Benzodiazepines: Uses, Dangers, and Clinical Considerations. Neurology International 13:4, pages 594-607.
Crossref
Mélinée Chapoutot, Laure Peter-Derex, Hélène Bastuji, Wendy Leslie, Benjamin Schoendorff, Raphael Heinzer, Francesca Siclari, Alain Nicolas, Patrick Lemoine, Susan Higgins, Alexia Bourgeois, Guillaume T. Vallet, Royce Anders, Marc Ounnoughene, Jessica Spencer, Francesca Meloni & Benjamin Putois. (2021) Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders. International Journal of Environmental Research and Public Health 18:19, pages 10222.
Crossref
Alexander Sweetman, Stacey Putland, Leon Lack, R.Doug McEvoy, Robert Adams, Ron Grunstein, Nigel Stocks, Billingsley Kaambwa, Emer Van Ryswyk, Christopher Gordon, Andrew Vakulin & Nicole Lovato. (2021) The effect of cognitive behavioural therapy for insomnia on sedative-hypnotic use: A narrative review. Sleep Medicine Reviews 56, pages 101404.
Crossref
Sarah K. Fineberg, Swapnil Gupta & Jacob Leavitt. (2019) Collaborative Deprescribing in Borderline Personality Disorder: A Narrative Review. Harvard Review of Psychiatry 27:2, pages 75-86.
Crossref
Karin Elsesser & Gudrun Sartory. 2018. Lehrbuch der Verhaltenstherapie, Band 2. Lehrbuch der Verhaltenstherapie, Band 2 369 389 .
Dirk K. Wolter. (2017) Suchtpotenzial und andere Risiken von Benzodiazepinen und Z-Drugs im Alter. SUCHT 63:2, pages 81-97.
Crossref
Catherine D Darker, Brion P Sweeney, Joe M Barry, Michael F Farrell & Erica Donnelly-Swift. (2015) Psychosocial interventions for benzodiazepine harmful use, abuse or dependence. Cochrane Database of Systematic Reviews.
Crossref
Lois W. Choi-Kain & Ana M. Rodriguez-Villa. 2015. Borderline Personality and Mood Disorders. Borderline Personality and Mood Disorders 39 63 .
Amit Arora, Andrew O'Neill, Peter Crome & Finbarr C. Martin. 2014. Substance Use and Older People. Substance Use and Older People 35 55 .
Phern-Chern Tor, Tze Pin Ng, Kian-Hui Yong, Kang Sim, Yu-Tao Xiang, Chuan-Yue Wang, Edwin Ho Ming Lee, Senta Fujii, Shu-yu Yang, Mian-Yoon Chong, Gabor S. Ungvari, Tianmei Si, Yan Ling He, Eun Kee Chung, Kok-Yoon Chee, Jintendra Trivedi, Pichet Udomratn, Naotaka Shinfuku, Ee Heok Kua, Chay Hoon Tan, Norman Sartorius & Ross J. Baldessarini. (2011) Adjunctive benzodiazepine treatment of hospitalized schizophrenia patients in Asia from 2001 to 2008. The International Journal of Neuropsychopharmacology 14:06, pages 735-745.
Crossref
Karin Elsesser & Gudrun Sartory. 2009. Lehrbuch der Verhaltenstherapie. Lehrbuch der Verhaltenstherapie 383 405 .
Austyn Snowden. (2008) Prescribing in anxiety. Nurse Prescribing 6:8, pages 349-356.
Crossref
B. Crackau, A. Zahradnik, I. Löhrmann, C. Otto, G. Bischof, U. John & H.-J. Rumpf. (2007) Kurzinterventionen bei MedikamentenabhängigenBrief intervention for cutting prescription drug use. Prävention und Gesundheitsförderung 3:1, pages 43-47.
Crossref
Deanna Mercer. (2007) Medications in the treatment of borderline personality disorder 2006. Current Psychiatry Reports 9:1, pages 53-62.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.